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a- and P-melanocyte-stimulating hormones (a-MSH and P-MSH) have been isolated from Xenopus luevis neurointer- 
mediate pituitary and microsequenced. Intracellular a-MSH is not N-acetylated after proteolytic processing of pro-opio- 
melanocortin in contrast to mammalian a-MSHs. There is a high preservation of the melanotropic amino acid sequence 
common to all MSHs although in Xenopus P-MSH a histidine residue replaces the glutamic acid residue found in position 
8 of mammalian l3-MSHs. 
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1. INTRODUCTION 
Mammalian (bovine, human and murine) pro- 
opiomelanocortins (POMC) have been fully 
characterized through cDNA [1,2] and gene se- 
quencing [3-51. Processing of this precursor (239 
residues), however, differs in the anterior and in- 
termediate lobes of the pituitary gland. Cor- 
ticotropin (39 residues), an excised fragment of 
POMC, is mainly found in the first lobe whereas 
in the second further maturation of this peptide 
leads to the 13-residue cu-melanocyte-stimulating 
hormone (cu-MSH) and the 22-residue cortico- 
tropin-like intermediary pituitary peptide (CLIP) 
[6]. On the other hand ,&-Iipotropin (91 residues), 
another fragment of POMC found in the anterior 
lobe, is split into ,&MSH (18 residues) and 
,&endorphin (31 residues) in the intermediate 
pituitary. This particular tissue-specific processing 
involves the sequential actions of a paired basic 
residue-specific endopeptidase [7], a carboxypep- 
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tidase B-like enzyme [8] and a peptidyl glycine LY- 
amidating monooxygenase [9, lo]. Furthermore in 
mammals the 13-residue (r-MSH is acetylated 
before secretion and this acetylation is necessary 
for displaying the full melanocytic activity [ 111. In 
amphibians, processing of POMC in neurointer- 
mediate lobe has been studied through the pulse- 
chase technique [12,13] but identification of the 
end products by amino acid sequence has not yet 
been performed. 
The nucleotide sequence of cloned cDNA for 
POMC from the amphibian Xenopus laevis has 
been determined and the amino acid sequence of 
the precursor has been deduced [14]. Xenopus 
laevis a-MSH and ,&MSH have now been isolated 
from neurointermediate pituitary glands and sub- 
jected to microsequencing. Whereas cleavages of 
the precursor occur as expected at paired basic 
residues, cu-MSH is not acetylated in contrast to its 
mammalian counterpart. 
2. MATERIALS AND METHODS 
2.1. Neurointermediate pituitaries 
Xenopus Iaevis (average body weight: 100 g), kindly provided 
by Professor J. Charlemagne from a breeding colony and kept 
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for several weeks in the laboratory, were killed by decapitation 
and the two lobes of the pituitary gland (adenohypophysial nd 
neurointermediate) were taken out and immediately used. 
Neurointermediate lobes (average weight: 1.2 mg) were 
homogenized with 0.1 M HCl (0.06 ml per gland) in a Potter- 
Elvehjem homogenizer for 4 min, then stirred for 4 h at 4°C. 
After centrifugation, the supernatant solution was recovered 
and subjected to high-pressure reverse-phase liquid 
chromatography. 
3. RESULTS AND DISCUSSION 
2.2. High-pressure reverse-phase liquid chromatography 
(HPLC) 
The supernatant was subjected to HPLC using a C-18 
Nucleosil column (4.5 x 210 mm, particle size 5 cm) and an 
acetonitrile linear gradient (S-60@/0) containing 0.05% 
trifluoroacetic acid was applied for 55 min, followed by an 
isocratic elution with 60% acetonitrile/0.05% trifluoroacetic 
acid solvent during 5 min. A model 204 Waters chromatograph 
equipped with a model U6K manual injector, a model 680 sol- 
vent programmer, a model 441 UV absorbance detector and a 
model 730 data module, was used. Absorbance was monitored 
at 214 and 280 nm. 0.6-ml fractions were collected. 
2.3. Amino acid microsequencing 
Purified peptides (about 0.1-l nmol) were subjected to 
microsequencing using an automated Edman degradation in an 
Applied Biosystems model 470 A gas-phase protein sequencer 
equipped with an on-line Applied Biosystems model 120 A 
analyzer under the conditions described by Hewick et al. [15]. 
Phenylthiohydantoin amino acids were identified and measured 
by high-pressure reverse-phase Iiquid chromatography in the 
on-line analyzer. 
Three neurointermediate lobes have been ex- 
tracted and the supernatant solution has been sub- 
jected to HPLC under the conditions described 
above. Several peptides have been detected (fig. 1). 
Vasotocin and mesotocin have been identified by 
their retention times (RT) compared with those of 
synthetic peptides, their amino acid compositions 
and sequences, and their biological activities [ 161. 
Materials corresponding to the peaks with RT 
25.00 and 28.25 min, respectively, have been con- 
centrated and submitted to microsequencing. 
Results are given in table 1. 
a-MSH can be recognized in the peak with RT 
28.25 min by its amino acid sequence up to residue 
10. This sequence is identical to the one deduced 
from the cDNA [14] assuming a processing 
cleavage at the pair of basic residues upstream 
alanine. Determination of the wMSH N-terminal 
sequence on the one hand proves the processing 
Microsequence analysis of Xenopus laevis cu-MSH and fi-MSH 
(material isolated from 3 neurointermediate lobes) 
Fig. 1. Separation of neurointermediate pituitary peptides of 
Xenopus laevis by HPLC. Retention times in minutes are 
indicated. 
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Table 1 
a-MSH &MSH 
(RT = 28.25) (RT = 25.00) 
Cycle Resi- Yield De- Cycle Resi- Yield De- 
due (pmol) duced due (pmol) duced 
from from 
DNA DNA 
1 Ala 36.5 Ala 1 unid. Asn 
2 Tyr 28.5 Tyr 2 GlY 22.5 Gly 
3 Ser 3.5 Ser 3 Asn 42.0 Asn 
4 Met 16.5 Met 4 Tyr 30.5 Tyr 
5 Glu 20.5 Glu 5 Arg 18.5 Arg 
6 His 21.0 His 6 Met 26.0 Met 
7 Phe 14.5 Phe 7 His 19.0 His 
8 Arg 10.0 Arg 8 His 16.0 His 
9 Trp 8.5 Trp 9 Phe 27.5 Phe 
10 GlY 4.0 Gly 10 Arg 12.5 Arg 
11 - - Lys 11 Trp 18.0 Trp 
12 - - Pro 12 GlY 12.0 Gly 
13 - - Val 13 Ser 2.5 Ser 
14 - - GUY 14 Pro 15.0 Pro 
15 - - Arg 15 Pro 9.5 Pro 
16 - Lys 16 Lys e2.0 Lys 
17 - - Asp 
18 - - Lys 
19 - - Arg 
unid., unidentified 
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cleavage, on the other shows that the N-terminal 
end is not acetylated in contrast to N-acetylated 
mammalian a-MSHs [l 11. The retention time of 
synthetic N-acetylated a-MSH (Ciba) is clearly dif- 
ferent (30.25 min). 
In a study on the processing of the frog Rana 
ridibunda POMC, it has been suggested, from 
HPLC behaviour, that intracellular a-MSH is not 
acetylated [13] and this feature might therefore be 
general in amphibians. It is likely that a second 
processing cleavage occurs in Xenopus POMC at 
the level of the pair Arg-Lys downstream and, 
through carboxypeptidase B and cu-amidase, valine 
is amidated as it is in mammalian ru-MSH. 
,&MSH can be recognized in the peak with RT 
25.00 min by the amino acid sequence up to 
residue 16. From the cDNA sequence and assum- 
ing a processing cleavage at the Lys-Lys pair 
upstream Asn, the amino acid sequence of 
Xenopus&MSH has been deduced [141. In our ex- 
periment, for an unknown reason, the first residue 
of the purified fl-MSH could not be identified but 
the 15 following amino acids are identical to those 
deduced (table 1). 
It can also be admitted that a second processing 
cleavage occurs at , the level of Lys-Arg 
downstream Asp-18 as in the mammalian in- 
termediate lobe, with separation of &MSH from 
&endorphin [ 171. C-terminal basic residues are 
subsequently removed by a carboxypeptidase B- 
like enzyme. 
A comparison of amino acid sequences of mam- 
malian and Xenopus laevis melanotropic peptides 
is shown in fig.2. There is a great conservation for 
a-MSHs since they differ only by the first residue 
(Ser or Ala). In the case of ,&MSHs, the number 
of variations is higher: positions 2, 4, 6 and 8 are 
different (fig.2). The melanotropic sequence com- 
mon to mammalian a-MSHs and ,&MSHs [l l] is 
preserved in amphibians. The replacement, 
however, of a glutamic acid residue by a histidine 
in the fourth position of this sequence in Xenopus 
&MSH is worthy to note. 
Substrate conformation-directed proteolytic 
processing has been suggested for vasopressin -
neurophysin - copeptin precursor involving a two- 
step maturation [ 18,191 and such a mechanism has 
been proposed for the cleavage of ,&lipotropin into 
,_______________________-___________________ 
I 
!!e!!E I I 
112 3 4 5 6 7 8 9 10 11 12 
Q, ox, Horse, Monkey Ac-SeriTyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly~Lya-Pra 1;’ 
I 
MPEIBIAtm 
xenopus 
Peptide 
cDNA 
I I I 6 I 
A~,c,;--_ ___ ___ ___ ___ ___ ___ ___ ___ 
Ly&q-A+_ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ 
4 
I I I 
B 
# 
I 
I 
I 
, 
IINUALS 
I 8 
1 2 3 415 6 7 0 9 10 11 12 13 14 15 
%s Asp-Glu-Gly-Pro:--- Lys ___ ___ ___ ___ ___ ___ ___ Ser ___ 
Monkey Asp-Glu-Gly-Pro;--- ArS ___ ___ ___ ___ ___ ___ ___ Ser ___ \ I 
AMPEIBIAUS 
0 
I 
, 
I 
XellODUS I 8 
Peptide X -Gly-As":--- Arg --_ ,qis --_ ___ ___ ___ ___ ser ___ 
I 
cDNA Lys-Lys-Aan-Gly-Asn;--- ArS --- His --- --- --_ ___ ___ Ser __- 
t I I-__________________________________________ 
I 
.i 
_j 
_; 
I 
I 
_. 
::l(NH*~ 
--- Gly-Arg-Lys-Arg-Arg 
t 
16 17 18 
Pro-Lys-Asp 
Pro-Lys-Asp 
Pro-Lya 
Pro-Lya-Asp-Lys-Arg-Tyr-Gly 
? 
Fig.2. Comparison of Xenopus luevis (Y-MSH and &MSH with mammalian counterparts. Amino acids identical to those of 
mammalian a-MSH are indicated by dashes. Homologous sequences in the two families, ru-MSHs and ,&MSHs, are boxed. 
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P-endorphin [20]. Pulse-chase studies using 
radioactive amino acids and sugars performed on 
mouse pituitary tumor cells (AtT-20) suggest hat 
20 kDa POMC is a branch-point in the processing 
pathways [21]. It can be converted either to 
4.5 kDa corticotropin by proteolytic processing or 
to 32 kDa POMC by the further addition of car- 
bohydrate, the 32 kDa form giving in turn a 
13 kDa glycosylated corticotropin. Because pro- 
teolytic processing of POMC differs in anterior 
and intermediate pituitary lobes although the same 
type of bibasic cleavage sites is involved, it seems 
of interest to compare the enzyme content of the 
secretory granules of both tissues. Furthermore, 
because a secreted acetylated form of (Y-MSH has 
been detected in amphibians [12,13], the 
acetylating enzyme is probably not present in the 
intermediate pituitary granules but perhaps in the 
plasma membrane, acting during exocytosis. 
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